BEAM
Price
$20.24
Change
+$0.41 (+2.07%)
Updated
May 2 closing price
Capitalization
2.04B
10 days until earnings call
KNSA
Price
$27.65
Change
-$0.09 (-0.32%)
Updated
May 2 closing price
Capitalization
2.02B
87 days until earnings call
Ad is loading...

BEAM vs KNSA

Header iconBEAM vs KNSA Comparison
Open Charts BEAM vs KNSABanner chart's image
Beam Therapeutics
Price$20.24
Change+$0.41 (+2.07%)
Volume$1.78M
Capitalization2.04B
Kiniksa Pharmaceuticals International
Price$27.65
Change-$0.09 (-0.32%)
Volume$662.35K
Capitalization2.02B
BEAM vs KNSA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. KNSA commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and KNSA is a Buy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (BEAM: $20.24 vs. KNSA: $27.65)
Brand notoriety: BEAM and KNSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. KNSA: 92%
Market capitalization -- BEAM: $2.04B vs. KNSA: $2.02B
BEAM [@Biotechnology] is valued at $2.04B. KNSA’s [@Biotechnology] market capitalization is $2.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, KNSA is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while KNSA’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • KNSA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KNSA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +3.69% price change this week, while KNSA (@Biotechnology) price change was +29.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

KNSA is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.04B) and KNSA($2.02B) have the same market capitalization . KNSA YTD gains are higher at: 39.788 vs. BEAM (-18.387). KNSA has higher annual earnings (EBITDA): -43.92M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. KNSA (244M). KNSA has less debt than BEAM: KNSA (9.86M) vs BEAM (161M). KNSA has higher revenues than BEAM: KNSA (423M) vs BEAM (63.5M).
BEAMKNSABEAM / KNSA
Capitalization2.04B2.02B101%
EBITDA-383.98M-43.92M874%
Gain YTD-18.38739.788-46%
P/E RatioN/A164.54-
Revenue63.5M423M15%
Total Cash851M244M349%
Total Debt161M9.86M1,634%
FUNDAMENTALS RATINGS
KNSA: Fundamental Ratings
KNSA
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKNSA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 30 days ago
85%
Bearish Trend 12 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGHAX73.86N/A
N/A
Vanguard Health Care Adm
JLPZX16.13N/A
N/A
JPMorgan US Large Cap Core Plus R2
AGCWX16.85N/A
N/A
American Century Global Small Cap R
HFDRX17.39N/A
N/A
Hartford Schroders US MidCap Opps R3
FQTEX12.16N/A
N/A
Franklin Templeton SMACS: Series E Adv

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
-0.32%
BEAM - KNSA
40%
Loosely correlated
+2.07%
ABVC - KNSA
40%
Loosely correlated
+1.94%
RGNX - KNSA
36%
Loosely correlated
+5.80%
ETNB - KNSA
36%
Loosely correlated
+7.38%
AMRN - KNSA
36%
Loosely correlated
-0.64%
More